| Announce Date | 11/25/2025 |
| EPS Normalized Actual | $2.67 (Beat by $0.17) |
| EPS GAAP Actual | $2.67 (Beat by $0.17) |
| Revenue Actual | $1.853B |
| Revenue Surprise | Beat by $1853M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.44795 |
| EPS GAAP Estimate | $2.44795 |
| Revenue Estimate | $1.819706119B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2029 | 14.04 | 17.12 | 13.78894 | 14.4569 | 7 |
| Jan 2028 | 12.27 | 19.59 | 11.71697 | 12.64037 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 1.61 | -0.7944 | 1.853B | 29.36% | 167.71M |
| FQ3 2025 (Jul 2025) | 1.47 | -0.76342 | 1.763B | 19.51% | 142.02M |
| FQ2 2025 (Apr 2025) | 0.71 | 0.71 | 1.633B | 17.88% | 1633M |
| FQ1 2025 (Jan 2025) | 1.42 | 1.42 | 1.532B | 11.68% | 1532M |
| FQ4 2024 (Oct 2024) | -2.48 | -2.48 | 1.309B | -1.3% | 1309M |
| FQ3 2024 (Jul 2024) | 1.31 | 1.31 | 1.419B | 9.51% | 1419M |
| FQ2 2024 (Apr 2024) | 1.17 | 1.17 | 1.341B | 9.99% | 1341M |
| FQ1 2024 (Jan 2024) | 1.31 | 1.31 | 1.353B | 2.59% | 1353M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
2.44795
Consensus Revenue Estimates
1.819706119B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 3.41539 | -- | 3.31521 | 3.43548 | 12 |
| FQ4 2027 (Oct 2027) | 3.22542 | -- | 3.13081 | 3.2444 | 11 |
| FQ3 2027 (Jul 2027) | 3.22578 | -- | 3.13116 | 3.24476 | 17 |
| FQ2 2027 (Apr 2027) | 2.81564 | -- | 2.80455 | 2.83234 | 10 |
| FQ1 2027 (Jan 2027) | 2.85681 | -- | 2.85681 | 2.85681 | 8 |
| FQ4 2026 (Oct 2026) | 3.00598 | 46.44 | 2.93334 | 3.06298 | 5 |
| FQ3 2026 (Jul 2026) | 2.69259 | 45.41 | 2.62753 | 2.74364 | 5 |
| FQ2 2026 (Apr 2026) | 2.33688 | 69.62 | 2.28041 | 2.38119 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 2.21B | -- | 2.16B | 2.22B | 10 |
| FQ4 2027 (Oct 2027) | 2.14B | -- | 2.09B | 2.15B | 11 |
| FQ3 2027 (Jul 2027) | 2.09B | -- | 2.05B | 2.1B | 18 |
| FQ2 2027 (Apr 2027) | 1.99B | -- | 1.98B | 2B | 14 |
| FQ1 2027 (Jan 2027) | 2.07B | -- | 2.07B | 2.07B | 6 |
| FQ4 2026 (Oct 2026) | 2B | 7.58 | 1.97B | 2.03B | 6 |
| FQ3 2026 (Jul 2026) | 1.92B | 8.17 | 1.88B | 1.95B | 6 |
| FQ2 2026 (Apr 2026) | 1.82B | 10.23 | 1.79B | 1.85B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.4044 | 1.61 | -0.7944 | -49.34% |
| FQ3 2025 (Jul 2025) | 2.23342 | 1.47 | -0.76342 | -51.93% |
| FQ2 2025 (Apr 2025) | 0.71 | 0.71 | 100% | |
| FQ1 2025 (Jan 2025) | 1.42 | 1.42 | 100% | |
| FQ4 2024 (Oct 2024) | -2.48 | -2.48 | 100% | |
| FQ3 2024 (Jul 2024) | 1.31 | 1.31 | 100% | |
| FQ2 2024 (Apr 2024) | 1.17 | 1.17 | 100% | |
| FQ1 2024 (Jan 2024) | 1.31 | 1.31 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $1.69B | $1.85B | $167.71M | 9.05% |
| FQ3 2025 (Jul 2025) | $1.62B | $1.76B | $142.02M | 8.06% |
| FQ2 2025 (Apr 2025) | $0B | $1.63B | $1633M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $1.53B | $1532M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $1.31B | $1309M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $1.42B | $1419M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $1.34B | $1341M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $1.35B | $1353M | 100% |